Newsroom / COVID-19

In the US, use of the Mitra device with blood is limited to research and non-diagnostic applications. In many countries outside the US, the Mitra device is approved as a remote blood sample collection device for some clinical applications, as referenced in some of the news content posted here.

by Neoteryx, on April 22,2021

At the end of March 2021, Quanterix Corporation issued a press release announcing that its Simoa® technology had been used in a research study to detect the SARS-CoV-2 virus. According …

Read Story
Topics:

by Neoteryx, on March 17,2021

AUCKLAND, NEW ZEALAND – March 2021 – New Zealand has proved to be one of the most successful nations in responding effectively to the coronavirus pandemic and controlling the spread …

Read Story
Topics:

by Neoteryx, on July 18,2020

According to a July 15, 2020 announcement posted on NewsWise, Vysnova Partners Inc., Wake Forest Baptist Health, and several other health organizations have received a $54-million contract from the US …

Read Story
Topics:

by Neoteryx, on July 16,2020

An article by Jen A. Miller in AACC’s July 2020 online issue of Clinical Laboratory News reports that the COVID-19 pandemic has sparked wider use of telehealth, and a push …

Read Story
Topics:

by Christa Nuber, on July 8,2020

Blood collection for COVID-19 testing aims to protect employees, students and soldiers. As businesses, universities and the Armed Forces begin reopening during the coronavirus pandemic—before a working vaccine against COVID-19 …

Read Story
Topics:

The latest product releases, company news and microsampling industry updates from Neoteryx.

search our newsroom

news reporter resources:

If you don’t find the information & assets you need via the buttons below, please contact us here: press@neoteryx.com

Fact Sheet & FAQs

social media

subscribe to news